Format

Send to:

Choose Destination
See comment in PubMed Commons below
Arch Otolaryngol Head Neck Surg. 1999 Jun;125(6):615-20.

Mal de debarquement.

Author information

  • 1Department of Neurology, Northwestern University Medical School, Chicago, Ill 60611, USA. thain@casbah.acns.nwu.edu

Abstract

MAIN OUTCOME MEASURE:

Clinical features of mal de debarquement syndrome.

RESULTS:

Nearly all respondents were middle-aged women (26 of 27; mean age, 49.3 years). The duration of symptoms ranged from 6 months to 10 years (mean, 3.5 years; SD, 2.5 years). The symptoms were constant in 23 (85%) patients. Neither meclizine hydrochloride nor transdermal scopolamine was helpful. Benzodiazepines were of the most benefit. Balance rehabilitation physical therapy was undertaken by 15 patients, who on average reported a small benefit.

CONCLUSIONS:

More than double the number of previously reported cases of mal de debarquement syndrome were identified by this study. The syndrome usually occurs in middle-aged women following an ocean cruise. Symptoms are often refractory to vestibular suppressants as well as physical therapy.

Comment in

PMID:
10367916
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk